Use in Pregnancy: (Pregnancy Risk Factor: C).
There are no well-controlled or adequate studies in pregnant women. IMCITIN should be used during pregnancy only if the potential benefit justifies the potential risk to mother and fetus.
Use in Lactation: Imipenem has been detected in human milk. If the use of IMCITIN is deemed essential, the patient should stop nursing.
Other Services
Country
Account